Studies Examine Cost-Effectiveness of Maternal RSV Vaccination, Nirsevimab in Infants
Seasonal maternal RSV vaccination may be cost-effective, as well as nirsevimab, particularly for those with higher risks
CDC Reports Infant Death From Listeria Outbreak Tied to Ready-to-Eat Meats
More than 72,000 pounds of meat and poultry products made by Yu Shang Food have been recalled
President-Elect Trump Names His Picks to Head the CDC and FDA
In addition, the president-elect has chosen his nominee for surgeon general
Younger Patients More Affected by Neurologic Manifestations of Long COVID
Younger and middle-aged patients have higher burden of neurologic symptoms, fatigue, sleep disturbance, cognitive dysfunction
Bird Flu Virus in Canadian Teen Shows Mutations That Could Help It Spread Among...
Optimal Timing of Maternal RSV Vaccine Determined to Be at Least Five Weeks Before...
Maternal vaccination two to three or three to four weeks before delivery linked to lower cord:maternal transfer ratios versus at least five weeks
COVID-19 Mortality Higher for Leukemia, Myelodysplastic Syndrome Patients
However, risk for hospitalization no higher for COVID-19 in these patients
E. Coli Fears Spur Recall of 167,000 Pounds of Ground Beef
Study Assesses Risk for 28-Day Hospitalization for Adults With RSV
In three databases, 4.5, 6.0, and 6.2 percent of medically attended RSV patients experienced 28-day all-cause hospitalization
